UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

Breast care (Basel, Switzerland), 2021-10, Vol.16 (5), p.523-531

2021

Volltextzugriff (PDF)

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

Scientific reports, 2018-11, Vol.8 (1), p.16861-10, Article 16861

2018

Volltextzugriff (PDF)

Prognosis and Prediction in Breast Cancer: Is There a Need for Further Tests?

The journal of applied laboratory medicine, 2018-09, Vol.3 (2), p.159-162

2018

Volltextzugriff (PDF)

The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges

Disease markers, 2017-01, Vol.2017 (2017), p.1-14

2017

Volltextzugriff (PDF)

Die Zukunft der theologischen Ausbildung ist ökumenisch: Interkulturelle und interkonfessionelle Herausforderungen in Universität und Schule, Kirche und Diakonie

Ulrike Link-Wieczorek, Wilhelm Richebächer, Olaf Waßmuth, Ulrike Link-Wieczorek, Wilhelm Richebächer, Olaf Waßmuth

2020

Volltextzugriff (PDF)

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

Breast care (Basel, Switzerland), 2018-12, Vol.13 (6), p.425-433

2018

Volltextzugriff (PDF)

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.4984-4994

2002

Volltextzugriff (PDF)

Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression

Journal of cellular physiology, 1999-08, Vol.180 (2), p.225-235

1999

Volltextzugriff (PDF)

Abstract P3-08-65: PITX2 DNA methylation: A prognostic/predictive biomarker for anthracycline-based chemotherapy

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-08-65

2020

Volltextzugriff (PDF)

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

JAMA oncology, 2017-07, Vol.3 (7), p.913

2017

Volltextzugriff (PDF)

(4-Aminomethyl)Phenylguanidine Derivatives as Nonpeptidic Highly Selective Inhibitors of Human Urokinase

Proceedings of the National Academy of Sciences - PNAS, 2000-05, Vol.97 (10), p.5113-5118

2000

Volltextzugriff (PDF)

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)

Cancer gene therapy, 2000-02, Vol.7 (2), p.292-299

2000

Volltextzugriff (PDF)

ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinical trials

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4507-4507

2013

Volltextzugriff (PDF)

Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis

Journal of Obstetrics and Gynaecology, 1995-04, Vol.21 (2), p.151-165

1995

Volltextzugriff (PDF)

Entwicklungen der forschenden Pharmaindustrie

Breast care (Basel, Switzerland), 2012-04, Vol.7 (2), p.155-164

2012

Volltextzugriff (PDF)

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)

International journal of oncology, 1998-11, Vol.13 (5), p.893

1998

Volltextzugriff (PDF)

Epitope Mapping of Monoclonal Antibodies Directed to PAI-1 Using PAI-1/PAI-2 Chimera and PAI-1-Derived Synthetic Peptides

Thrombosis research, 2000-04, Vol.98 (1), p.73-81

2000

Volltextzugriff (PDF)

The Urokinase Receptor Is a Major Vitronectin-Binding Protein on Endothelial Cells

Experimental cell research, 1996-05, Vol.224 (2), p.344-353

1996

Volltextzugriff (PDF)

Interaction of plasminogen activator inhibitor type‐1 (PAI‐1) with vitronectin

European journal of biochemistry, 2002-01, Vol.269 (1), p.184-192

2002

Volltextzugriff (PDF)

Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex

Biological chemistry Hoppe-Seyler, 1994-09, Vol.375 (9), p.603-608

1994

Volltextzugriff (PDF)

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

FEBS letters, 1998-10, Vol.438 (1), p.101-105

1998

Volltextzugriff (PDF)

PITX2 DNA-methylation as the first clinically validated predictive marker for anthracycline based chemotherapy in high-risk breast cancer patients

Meta Gene, 2018-09, Vol.17, p.S17-S18

2018

Volltextzugriff (PDF)

Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1

Nucleic acids research, 1995-10, Vol.23 (19), p.3887-3893

1995

Volltextzugriff (PDF)

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice

Clinical & experimental metastasis, 1995-07, Vol.13 (4), p.296-302

1995

Volltextzugriff (PDF)

Coronary Thrombolysis and Reperfusion - Literature Review and Future Projections

Seminars in interventional radiology, 1992-09, Vol.9 (3), p.195-207

1992

Volltextzugriff (PDF)

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(260)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(135)
Humans
(84)
Female
(57)
Biological And Medical Sciences
(50)
Animals
(47)
Male
(35)
Medical Sciences
(27)
Fundamental And Applied Biological Sciences. Psychology
(24)
Neurosciences & Neurology
(23)
Oncology
(23)
Immunohistochemistry
(21)
Adult
(17)
Guinea Pigs
(17)
Physical Sciences
(17)
Aged
(16)
Biochemistry & Molecular Biology
(16)
Middle Aged
(16)
Neurosciences
(15)
Mice
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(6)
Hearing Research
(5)
Brain Research
(4)
Der Unfallchirurg
(4)
Journal Of Clinical Oncology
(4)
Neuroscience Letters
(4)
Angewandte Chemie International Edition
(3)
Biological Chemistry
(3)
Breast Care
(3)
Cancer Research
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

Prognosis and Prediction in Breast Cancer: Is There a Need for Further Tests?

The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges

Die Zukunft der theologischen Ausbildung ist ökumenisch: Interkulturelle und interkonfessionelle Herausforderungen in Universität und Schule, Kirche und Diakonie

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression

Abstract P3-08-65: PITX2 DNA methylation: A prognostic/predictive biomarker for anthracycline-based chemotherapy

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

(4-Aminomethyl)Phenylguanidine Derivatives as Nonpeptidic Highly Selective Inhibitors of Human Urokinase

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)

ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinical trials

Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis

Entwicklungen der forschenden Pharmaindustrie

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)

Epitope Mapping of Monoclonal Antibodies Directed to PAI-1 Using PAI-1/PAI-2 Chimera and PAI-1-Derived Synthetic Peptides

The Urokinase Receptor Is a Major Vitronectin-Binding Protein on Endothelial Cells

Interaction of plasminogen activator inhibitor type‐1 (PAI‐1) with vitronectin

Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

PITX2 DNA-methylation as the first clinically validated predictive marker for anthracycline based chemotherapy in high-risk breast cancer patients

Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice

Coronary Thrombolysis and Reperfusion - Literature Review and Future Projections

Suchergebnisse filtern